Brian J. Linder, M.D.

Closed for Enrollment

• Multi-Institutional Study To Evaluate DNA Methylation Markers For Detection of Primary Bladder Cancers In Urine Samples From a Cohort Of Patients With Hematuria. Rochester, Minn.

  The primary objective of this study is to evaluate the performance of the methylation marker

  panel for the detection of bladder cancer in patients with gross or microscopic hematuria.

  The secondary objective is to evaluate the predictive accuracy of a risk model including clinical

  factors such as age, gender, smoking history, and presence of gross versus microscopic hematuria compared to a model incorporating the same risk factors along with the methylation

  marker panel.